2011Journal of Taishan Medical CollegeRequires access

Analysis of drug resistance and distribution in Escherichia coli from urine

Shuang Liu

Open publisher page 0 citations

Abstract

Objective: To investigate drug resistance and clinical distribution of E.coli isolated from urine in hospital,and to provide the guidance for the rational clinical application of antibiotics.Methods:161 strains of E.coli were isolated from urine from June 2010-February 2011,whose drug resistance rates and clinical distribution were analyzed retrospectively.Results: 161 strains of E.coli were collected mainly from the Department of Urology(62.7%),Intensive Care Unit(13%) and Medical Wards(10%).Resistance rates to imipenem,meropenem,ertapenem,piperacillin/tazobactam,cefoxitin,cefepime,ceftazidime,aztreonam,amoxicillin/clavulanic,cefotaxime,tobramycin,cidomycin,levofloxacin,ciprofloxacin,SMZ-TMP,cefazolin,furadantin and ampicillin were 0.00%,0.00%,0.00%,5.6%,16.8%,23%,26.7%,33.5%,43.5%,48.4%,50.9%,52.8%,60.9%,62.1%,73.9%,80.7%,90.1% and 92.5%.Conclusion: E.coli is common pathogen which can cause urinary tract infection and the antibiotics should be chosen according to drug sensitivity test in the clinical practice.

About this research paper

What this paper is about

Objective: To investigate drug resistance and clinical distribution of E.coli isolated from urine in hospital,and to provide the guidance for the rational clinical application of antibiotics.Methods:161 strains of E.coli were isolated from urine from June 2010-February 2011,whose drug resistance rates and clinical distribution were analyzed retrospectively.Results: 161 strains of E.coli were collected mainly from the Department of Urology(62.7%),Intensive Care Unit(13%) and Medical Wards(10%).Resistance rates to imipenem,meropenem,ertapenem,piperacillin/tazobactam,cefoxitin,cefepime,ceftazidime,aztreonam,amoxicillin/clavulanic,cefotaxime,tobramycin,cidomycin,levofloxacin,ciprofloxacin,SMZ-TMP,cefazolin,furadantin and ampicillin were 0.00%,0.00%,0.00%,5.6%,16.8%,23%,26.7%,33.5%,43.5%,48.4%,50.9%,52.8%,60.9%,62.1%,73.9%,80.7%,90.1% and 92.5%.Conclusion: E.coli is common pathogen which can cause urinary tract infection and the antibiotics should be chosen according to drug sensitivity test in the clinical practice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate drug resistance and clinical distribution of E.coli isolated from urine in hospital,and to provide the guidance for the rational clinical application of antibiotics.Methods:161 strains of E.coli were isolated from urine from June 2010-February 2011,whose drug resistance rates and clinical distribution were analyzed retrospectively.Results: 161 strains of E.coli were collected mainly from the Department of Urology(62.7%),Intensive Care Unit(13%) and Medical Wards(10%).Resistance rates to imipenem,meropenem,ertapenem,piperacillin/tazobactam,cefoxitin,cefepime,ceftazidime,aztreonam,amoxicillin/clavulanic,cefotaxime,tobramycin,cidomycin,levofloxacin,ciprofloxacin,SMZ-TMP,cefazolin,furadantin and ampicillin were 0.00%,0.00%,0.00%,5.6%,16.8%,23%,26.7%,33.5%,43.5%,48.4%,50.9%,52.8%,60.9%,62.1%,73.9%,80.7%,90.1% and 92.5%.Conclusion: E.coli is common pathogen which can cause urinary tract infection and the antibiotics should be chosen according to drug sensitivity test in the clinical practice.

Key concepts: Ertapenem, Meropenem, Cefepime, Medicine, Piperacillin, Tazobactam, Aztreonam, Imipenem

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of drug resistance and distribution in Escherichia coli from urine — Research Paper | ScholarLens